全文获取类型
收费全文 | 2095篇 |
免费 | 85篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 42篇 |
妇产科学 | 80篇 |
基础医学 | 295篇 |
口腔科学 | 89篇 |
临床医学 | 194篇 |
内科学 | 411篇 |
皮肤病学 | 46篇 |
神经病学 | 132篇 |
特种医学 | 129篇 |
外科学 | 217篇 |
综合类 | 20篇 |
一般理论 | 1篇 |
预防医学 | 112篇 |
眼科学 | 42篇 |
药学 | 125篇 |
中国医学 | 2篇 |
肿瘤学 | 237篇 |
出版年
2023年 | 8篇 |
2022年 | 12篇 |
2021年 | 23篇 |
2020年 | 15篇 |
2019年 | 32篇 |
2018年 | 32篇 |
2017年 | 27篇 |
2016年 | 40篇 |
2015年 | 35篇 |
2014年 | 66篇 |
2013年 | 109篇 |
2012年 | 107篇 |
2011年 | 137篇 |
2010年 | 80篇 |
2009年 | 74篇 |
2008年 | 139篇 |
2007年 | 122篇 |
2006年 | 128篇 |
2005年 | 151篇 |
2004年 | 145篇 |
2003年 | 118篇 |
2002年 | 116篇 |
2001年 | 33篇 |
2000年 | 19篇 |
1999年 | 38篇 |
1998年 | 24篇 |
1997年 | 32篇 |
1996年 | 20篇 |
1995年 | 14篇 |
1994年 | 12篇 |
1993年 | 18篇 |
1992年 | 18篇 |
1991年 | 15篇 |
1990年 | 20篇 |
1989年 | 13篇 |
1988年 | 4篇 |
1987年 | 11篇 |
1986年 | 15篇 |
1985年 | 17篇 |
1984年 | 18篇 |
1983年 | 13篇 |
1982年 | 9篇 |
1981年 | 6篇 |
1979年 | 5篇 |
1978年 | 11篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1975年 | 9篇 |
1974年 | 6篇 |
1973年 | 6篇 |
排序方式: 共有2184条查询结果,搜索用时 15 毫秒
81.
Johann Kinzl Wilfried Biebl Manfred Herold 《The International journal of eating disorders》1993,13(1):117-124
The authors investigated the significance of vomiting for hyperamylasemia and sialadenosis in patients with bulimia nervosa. Hyperamylasemia was found in 61% of the bulimics and in 20% of the restrictor anorectics but in no patients with binge-eating syndrome. In more than three fourths of the bulimics there was a close positive correlation between the frequency of vomiting and total serum amylase levels. Both frequency and type of vomiting seem to be relevant to the extent of salivary gland enlargement. The significance of vomiting for the etiopathology of hyperamylasemia and for the diagnosis of eating disorders will be discussed. © 1993 by John Wiley & Sons, Inc. 相似文献
82.
Jan Jacques Michiels Huub H D M van Vliet Zwi Berneman Alain Gadisseur Marc van der Planken Wilfried Schroyens Ann van der Velden Ulrich Budde 《Clinical and applied thrombosis/hemostasis》2007,13(1):14-34
The current standard set of von Willebrand factor (VWF) parameters used to differentiate type 1 from type 2 VWD include bleeding times (BTs), factor VIII coagulant activity (FVIII:C), VWF antigen (VWF:Ag), VWF ristocetine cofactor activity (VWF:RCo), VWF collagen binding activity (VWF:CB), ristocetine induced platelet aggregation (RIPA), and analysis of VWF multimers in low and high resolution agarose gels and the response to DDAVP. The BTs and RIPA are normal in asymptomatic carriers of a mutant VWF allele, in dominant type 1, and in recessive type 2N VWD, and this category has a normal response of VWF parameters to DDAVP. The response of FVIII:C is compromised in type 2N VWD. The BTs and RIPA are usually normal in type Vicenza and mild type 2A VWD, and these two VWD variants show a transiently good response of BT and VWF parameters followed by short in vivo half life times of VWF parameters. The BTS are strongly prolonged and RIPA typically absent in recessive severe type 1 and 3 VWD, in dominant type 2A and in recessive type 2C (very likely also 2D) VWD and consequently associated with low or absent platelet VWF, and no or poor response of VWF parameters to DDAVP. The BTs are prolonged and RIPA increased in dominant type 2B VWD, that is featured by normal platelet VWF and a poor response of BT and functional VWF to DDAVP. The BTs are prolonged and RIPA decreased in dominant type 2A and 2U, that all have low VWF platelet, very low VWF:RCo values as compared to VWF:Ag, and a poor response of functional VWF to DDAVP. VWD type 2M is featured by the presence of all VWF multimers in a low resolution agarose gel, normal or slightly prolonged BT, decreased RIPA, a poor response of VWF:RCo and a good response of FVIII and VWF:CB to DDAVP and therefore clearly in between dominant type 1 and 2U. The existing recommendations for prophylaxis and treatment of bleedings in type 2 VWD patients with FVIII/VWF concentrates are mainly derived from pharmocokinetic studies in type 3 VWD patients. FVIII/VWF concentrates should be characterised by labelling with FVIII:C, VWF:RCo, VWF:CB and VWF multimeric pattern to determine their safety and efficacy in prospective management studies. As the bleeding tendency is moderate in type 2 and severe in type 3 VWD and the FVIII:C levels are near normal in type 2 and very low in type 3 VWD patients. Proper recommendations of FVIII/VWF concentrates using VWF:RCo unit dosing for the prophylaxis and treatment of bleeding episodes are proposed and has to be stratified for the severity of bleeding, the type of surgery either minor or major and for type 2 and type 3 VWD as well. 相似文献
83.
84.
Out R Jessup W Le Goff W Hoekstra M Gelissen IC Zhao Y Kritharides L Chimini G Kuiper J Chapman MJ Huby T Van Berkel TJ Van Eck M 《Circulation research》2008,102(1):113-120
The concept that macrophages can become foam cells as a result of a disturbed balance between the uptake of cholesterol from lipoproteins and cholesterol efflux is generally accepted. ABCA1 and ABCG1 are two cholesterol transporters that may act sequentially to remove cellular cholesterol, but currently their combined role in vivo is unknown. We report here that targeted disruption of both ABCA1 and ABCG1 in mice, despite severe plasma hypocholesterolemia, leads to massive lipid accumulation and foam cell formation of tissue macrophages. A complete ablation of cellular cholesterol efflux in vitro is observed, whereas in vivo macrophage-specific reverse cholesterol transport to the feces is markedly decreased. Despite the massive foam cell formation of tissue macrophages, no lipid accumulation was observed in the vascular wall, even in mice of 1 year old, indicating that the double knockout mice, possibly because of their hypocholesterolemia, lack the trigger to attract macrophages to the vessel wall. In conclusion, even under hypocholesterolemic conditions macrophages can be converted into foam cells, and ABCA1 and ABCG1 play an essential role in the prevention of foam cell formation. 相似文献
85.
Dr. Wilfried Zeller 《Journal of molecular medicine (Berlin, Germany)》1927,6(14):655-656
Ohne Zusammenfassung 相似文献
86.
87.
88.
Despite its widespread availability and known safety and efficacy, a therapy with intravenous thrombolysis is still undergiven. We aimed to identify whether nationwide quality projects—like the stroke registry in Austria—as well as online benchmarking and predefined target values can increase rates of thrombolysis. Therefore, we assessed 6,394 out of 48,462 patients with ischemic stroke from the Austrian stroke registry (study period from March 2003 to December 2011) who had undergone thrombolysis treatment. We defined lower level and target values as quality parameters and evaluated whether or not these parameters could be achieved in the past years. We were able to show that rates of thrombolysis in Austria increased from 4.9 % in 2003 to 18.3 % in 2011. In a multivariate regression model, the main impact seen was the increase over the years [the OR ranges from 0.47 (95 % CI 0.32–0.68) in 2003 to 2.51 (95 % CI 2.20–2.87) in 2011). The predefined lower and target levels of thrombolysis were achieved at the majority of participating centers: in 2011 the lower value of 5 % was achieved at all stroke units, and the target value of 15 % was observed at 21 of 34 stroke units. We conclude that online benchmarking and the concept of defining target values as a tool for nationwide acute stroke care appeared to result in an increase in the rate of thrombolysis over the last few years while the variability between the stroke units has not yet been reduced. 相似文献
89.
Lieven Annemans Philippe Beutels David E. Bloom Wilfried De Backer Olivier Ethgen Jeroen Luyten Philippe Van Wilder Lander Willem Steven Simoens 《Value in health》2021,24(1):105-111
ObjectivesThe standard framework of economic evaluation of health programs, which is increasingly used for policy funding decisions, is insufficiently equipped to reflect the full range of health and economic benefits conferred by vaccines and thus undervalues vaccination.MethodsIn 2019, a group of Belgian health economic and clinical experts, supported by 2 senior international vaccination experts (1 American, 1 Belgian), convened 4 roundtable meetings to highlight which particular value elements of vaccination remain neglected in economic evaluations.ResultsThey concluded that the standard economic evaluation framework fails to reflect the full value of vaccination with respect to prevention of complications linked to some vaccine-preventable diseases, health gains for caregivers, herd effects, changes in exposure to and distribution of serotypes, the effect on antimicrobial resistance, productivity gains for caregivers and patients, and the distributive implications of vaccination programs.ConclusionsHere, suggestions are made regarding how these shortcomings can be addressed in future economic evaluations of vaccines and how a more level playing field between vaccines and other health programs can be created. 相似文献
90.